We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$11.2M
(+4.7%)
Cap. Flow
+$1.58M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$7.05M |
| 2 |
Amazon
AMZN
|
+$3.89M |
| 3 |
uniQure
QURE
|
+$2.86M |
| 4 |
BioNTech
BNTX
|
+$2.81M |
| 5 |
DexCom
DXCM
|
+$2.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$5.6M |
| 2 |
Procter & Gamble
PG
|
+$3.27M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$3.16M |
| 4 |
CVS Health
CVS
|
+$3.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.23% |
| 2 | Healthcare | 25.2% |
| 3 | Consumer Discretionary | 20.47% |
| 4 | Communication Services | 8.05% |
| 5 | Financials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Maravai LifeSciences
MRVI
$861M
| $19.1K | 0.01% |
1,336
+104
| +8% | +$1.64K |
|
177
Edwards Lifesciences
EW
$53.6B
| $19.1K | 0.01% |
256
| – | – |
|
|
VTYX
178
DELISTED
Ventyx Biosciences
VTYX
| $18.9K | 0.01% |
+575
| New | +$17K |
|
179
Arvinas
ARVN
$580M
| $18.5K | 0.01% |
541
+43
| +9% | +$1.81K |
|
180
Genmab
GMAB
$19.6B
| $18.4K | 0.01% |
434
+81
| +23% | +$3.34K |
|
181
Relay Therapeutics
RLAY
$4.4B
| $18.3K | 0.01% |
1,228
+208
| +20% | +$3.98K |
|
182
Pacira BioSciences
PCRX
$945M
| $18K | 0.01% |
466
+37
| +9% | +$1.8K |
|
183
Veracyte
VCYT
$3.59B
| $17.3K | 0.01% |
729
+58
| +9% | +$1.35K |
|
184
IQVIA
IQV
$39.8B
| $17.2K | 0.01% |
84
| – | – |
|
|
KDNY
185
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $17K | 0.01% |
649
+60
| +10% | +$1.33K |
|
186
Rhythm Pharmaceuticals
RYTM
$8.1B
| $16.7K | 0.01% |
572
+97
| +20% | +$2.49K |
|
|
SWTX
187
DELISTED
SpringWorks Therapeutics
SWTX
| $16.5K | 0.01% |
634
+171
| +37% | +$4.21K |
|
|
VRNA
188
DELISTED
Verona Pharma
VRNA
| $16.1K | 0.01% |
+617
| New | +$8.22K |
|
|
DAWN
189
DELISTED
Day One Biopharmaceuticals
DAWN
| $16.1K | 0.01% |
747
+59
| +9% | +$1.21K |
|
190
Xencor
XNCR
$1.72B
| $15.9K | 0.01% |
609
+50
| +9% | +$1.4K |
|
191
Agios Pharmaceuticals
AGIO
$2.04B
| $15.7K | 0.01% |
558
+45
| +9% | +$1.27K |
|
192
Syndax Pharmaceuticals
SNDX
$1.77B
| $15.6K | 0.01% |
612
+82
| +15% | +$1.91K |
|
|
RVNC
193
DELISTED
Revance Therapeutics, Inc.
RVNC
| $15.4K | 0.01% |
836
+152
| +22% | +$3.48K |
|
|
NUVL
194
DELISTED
Nuvalent
NUVL
| $15.4K | 0.01% |
518
+115
| +29% | +$3.21K |
|
|
KYNB
195
Kyntra Bio
KYNB
$28.7M
| $15.3K | 0.01% |
38
+3
| +9% | +$1.15K |
|
|
DICE
196
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $15.1K | 0.01% |
+484
| New | +$15.8K |
|
197
Rocket Pharmaceuticals
RCKT
$374M
| $15K | 0.01% |
769
+151
| +24% | +$2.78K |
|
198
Immunocore
IMCR
$1.77B
| $15K | 0.01% |
+262
| New | +$14.7K |
|
199
Recursion Pharmaceuticals
RXRX
$1.76B
| $14.2K | 0.01% |
1,846
+299
| +19% | +$2.93K |
|
200
MannKind Corp
MNKD
$1.24B
| $14.1K | 0.01% |
2,674
+264
| +11% | +$1.08K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2022 Portfolio in Review
As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
- China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
- China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
- China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
- China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
- China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
- China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.
Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.